Team identifies genes that increase risk for triple-negative breast cancer

Team identifies genes that increase risk for triple-negative breast cancer

by Mayo ClinicThis stylistic diagram shows a gene in relation to the double helix structure of DNA and to a chromosome (right). The chromosome is X-shaped because it is dividing. Introns are regi

Team identifies genes that increase risk for triple-negative breast cancer

by Mayo ClinicThis stylistic diagram shows a gene in relation to the double helix structure of DNA and to a chromosome (right). The chromosome is X-shaped because it is dividing. Introns are regi
Research team identifies a potential strategy in fight against brain cancer

Research team identifies a potential strategy in fight against brain cancer

by Virginia TechA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists with the Virginia Tech Carilion Research I

Research team identifies a potential strategy in fight against brain cancer

by Virginia TechA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists with the Virginia Tech Carilion Research I
Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj
Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl
Researches novel triple-negative breast cancer treatments

Researches novel triple-negative breast cancer treatments

by Medical University of South CarolinaDr. Antonio Giordano received an award that will help him research triple-negative breast cancer treatments. Credit: Sarah PackWorking with patients while a

Researches novel triple-negative breast cancer treatments

by Medical University of South CarolinaDr. Antonio Giordano received an award that will help him research triple-negative breast cancer treatments. Credit: Sarah PackWorking with patients while a
Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients: Study

Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients: Study

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainRegular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome

Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients: Study

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainRegular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome
Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of
Study confirms disparities in triple-negative breast cancer diagnoses

Study confirms disparities in triple-negative breast cancer diagnoses

by WileyCredit: CC0 Public DomainA new study published early online inCancer, a peer-reviewed journal of the American Cancer Society, shows that women of color and young women may face elev

Study confirms disparities in triple-negative breast cancer diagnoses

by WileyCredit: CC0 Public DomainA new study published early online inCancer, a peer-reviewed journal of the American Cancer Society, shows that women of color and young women may face elev
Colorectal cancer cells killed by assassin antibody, team finds

Colorectal cancer cells killed by assassin antibody, team finds

by University of SaskatchewanCredit: University of SaskatchewanColorectal cancer is the second leading cause of death from cancer in North America and is often diagnosed at an advanced stage, aft

Colorectal cancer cells killed by assassin antibody, team finds

by University of SaskatchewanCredit: University of SaskatchewanColorectal cancer is the second leading cause of death from cancer in North America and is often diagnosed at an advanced stage, aft
Team discovers secret to making immune cells better cancer killers

Team discovers secret to making immune cells better cancer killers

by University of VirginiaResearchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the

Team discovers secret to making immune cells better cancer killers

by University of VirginiaResearchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the